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Summary 
E-Sdectin is an inducible adhesion protein expressed by endothelial ceils and recognized by lenkocytes 
during their extravasation from the blood into inflamed tissues. Originally, E-sdectin was defined 
as a mydoid ceil-specific  adhesion protein, but recent studies have shown it to be recognized 
by human lymphocytes as well. These lymphocytes represent a memory T cell subset and have 
been shown to express the HECA-452 carbohydrate epitope (CLA + lymphocytes). We extend 
these findings and show that ruminant 3'/8 T cells bind E-sdectin as well; and we provide preliminary 
evidence that this interaction is mediated by a novel glycoprotein receptor on the lymphocyte. 
Unlike conventional T ceils (c~/13 T cells), 3'/8 T cells from neonatal and mature animals bind 
E-sdectin, suggesting that prior antigen stimulation and differentiation to a memory lymphocyte 
are not required for this interaction. Neuraminidase treatment of the 3'/8 T  cells or addition 
of ethylenediaminetetraacetic acid (EDTA) to the assay abrogates binding, demonstrating the 
importance of sialic acid and divalent cations, which is consistent with other E-sdectin-mediated 
adhesion events. However, previously defined E-selectin carbohydrate ligands, such as sialyl Lewis 
x on nentrophils and the HECA-452 epitope on human memory lymphocytes, are antigenically 
different than the carbohydrates  on ruminant 3'/8 T cells since the mAbs CSLEX and HECA- 
452 do not recognize these ceils. Protease treatment of 3'/8 T  ceils significantly inhibits their 
binding to E-sdectin; however, previously characterized adhesion glycoproteins, such as L-selectin, 
CD44, and CD18, are not involved in the adhesive event. An E-sdectin aflinity column purifies 
a single glycoprotein of 250 kD (280 kD under reducing conditions) from 3'/8 T cell detergent 
lysates. Nenraminidase digestion of the 250-kD product as well as EDTA abolishes binding to 
E-sdectin. Finally, E-sdectin expression in vivo appears to mediate 3'/8 T  cell accumulation. 
Stimulation of bovine skin with tumor necrosis factor o~ induced an increase in E-sdectin expression 
that was associated with an influx of 3'/8 T  cells at the same site. 
S 
electins are a new family of adhesion proteins that direct 
leukocyte entry into sites of inflammation and lymphoid 
tissue (1). Two vascular (P- and E-sdectin) and one leukocyte 
(L-selectin)  sdectin have been defined. From the predicted 
cDNA  sequences,  sdectins  are  composed  of  an  NHz- 
terminal, C-type lectin domain followed by an epidermal 
growth factor domain, and multiple short consensus repeats 
(SCR) 1 that are homologous to complement-binding pro- 
reins. Sdectins also have conventional transmembrane sequences 
and short cytoplasmic tails. The sdectin lectin domains are 
required for function and their carbohydrate-binding sped- 
1 Abbreviations used in thispaper: HEV, high endothdial cell venule; SCR, 
short consensus repeat; sLea, sialyl Lewis a; sLex, sialyl Lewis x; WC1, 
Workshop  Cluster 1. 
ficities have been partially defined. Sialylated Lewis carbohy- 
drate derivatives, such as sialyl Lewis x (sLex) and sialyl Lewis 
a (sLea), have been shown to function as sdectin llgands (2-4). 
E-Selectin was originally described as a mydoid call-specific 
adhesion protein whose expression on cytokine-activated en- 
dothelial ceUs in vivo was thought to direct the entry of nen- 
trophils and monocytes into sites of acute inflammation (5). 
However, E-sdectin has been found on venules in sites of 
chronic inflammation that are predominantly associated with 
infiltrates of mononuclear cells (6, 7). P,  ecently, human CD4 
memory T  ceils, but not virgin calls, have been shown to 
avidly bind E-sdeetin (8, 9). The capacity to bind E-sdectin 
after the acquisition of the memory phenotype is associated 
with the expression of the HECA-452 epitope (CLA antigen) 
on T cells (8,  10, 11). HECA-452 recognizes the "face"  of 
the carbohydrate moiety on lymphocytes that is bound by 
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tween memory T  cells and E-selectin may be important in 
the preferential accumulation of these lymphocytes in cer- 
tain inflammatory sites (8-10). Picker et al. (8,  10) have ex- 
tended this hypothesis, based on their observation that E-selec- 
tin appears  to be preferentially expressed  on venules in the 
skin, and proposed that E-selectin serves as a vascular addressin 
for lymphocyte recirculation through  dermal  tissue.  The 
testing of these hypotheses has not been done due to the fact 
that all information obtained thus far has been with human 
cells and not with cells from animal models. 
In many animals, including humans, 3'/8 T cells are thought 
to have the capacity to recirculate through epithelial cell-as- 
sociated tissues (13, 14), such as gut and skin, versus a prefer- 
ence of conventional T cells (c~/B) for secondary lymphoid 
organs (15). In particular, 3'//~ T cells in ruminants exhibit 
a considerable capacity to home to the skin (14). Since E-selec- 
tin may be a skin-specific  addressin, we tested if ruminant 
3"//~ T cells represent another lymphocyte subset that binds 
E-selectin. If true, the role of these interactions in vivo could 
eventually be tested. 
We  show that bovine 3'//~ T  cells  avidly bind  human 
E-selectin-transfected L cells. Unlike human CD4 T  cells, 
prior differentiation or acquisition of the HECA-452 epitope 
is not required for binding. In addition, neuraminidase or 
protease treatment of the 3'/8 T  cells blocks adhesion, but 
known adhesion proteins, such as CD18,  CD44,  and, im- 
portantly, L-selectin, appear to play no role in binding E-selec- 
tin. A single 250-kD glycoprotein, isolated from detergent 
lysates  of 3,/8 T  cells using an E-selectin affinity column, 
may serve as the E-selectin receptor on the lymphocyte. The 
interaction defined here appears important in vivo, since up- 
regulation of E-sdectin in bovine skin by injection of TNF-c~ 
increases the accumulation of 3'/8 T  cells at the same site. 
These results provide the first demonstration that lympho- 
cytes in an animal model bind E-selectin.  Thus, the role of 
this interaction in vivo can be tested. In addition, the 3'/~ 
T  cell's receptor for E-selectin may represent a member of 
a potentially new family of highly glycosylated surface pro- 
teins that serve as high affinity ligands for selectins. 
Materiah and Methods 
Animals.  Mixed-breed cattle, ranging in age from 1 to 4 wk, 
were purchased from local producers and housed at the Montana 
State University large animal facilities  at the Veterinary Molecular 
Biology Laboratory. Human and bovine peripheral blood was col- 
lected into heparinized tubes by venipuncture, and the PBMC were 
separated by centrifugation through Ficoll-Hypaque (histopaque 
1077; Sigma Chemical Co., St. Louis, MO). Bovine tissue samples 
were collected from the animals upon necropsy. 
Reagents.  The mAbs used in this report have been described 
dsewhere. DREG-56 is a mouse mAb that recognizes human (16) 
and bovine (17) L-selectin. IL-A29 (American Type Culture Col- 
lection, Rockville, MD) and BAQ4A (Veterinary  Medical  Research 
and Development, Pullman, WA) are mouse mAbs that recognize 
the Workshop Cluster I (WC1) antigens (also referred to as T19) 
specifically  expressed  by bovine, ovine, and caprine ~//5 T lympho- 
cytes (18-22). Hermes 3 (23-25) is a mouse mAb that recognizes 
CD44 (HCAM) on human leukocytes  and crossreacts with bovine 
lymphocytes (17). 60.3 (generously provided by John Harhn, 
University  of  Washington, Seattle, WA) is a mouse mAb that recog- 
nizes CD18 on human leukocytes (26) and crossreacts with rumi- 
nant leukocytes. ED246 (27) and CL2 (28) are mouse mAbs that 
recognize the SCR and lectin domains of  human E-selectin,  respec- 
tively. EL-246 also crossreacts with bovine L- (27) and E-selectin 
(M. A. Jutila, personal observation). EL-81 is a mouse mAb that 
recognizes a nonfunction-blocking epitope on human E-sdectin 
(27). CSLEX is a mouse mAb that recognizes the Lewis carbohy- 
drate derivative sLex (29), and it also crossreacts in the ruminant 
(M. A. Jutila, personal observation). HECA-452 is a rat mAb that 
recognizes a carbohydrate moiety expressed on high endothelial 
cell venules (HEV) (30), myeloid ceils (11), and the CLA antigen 
(12) expressed on a subset of human memory T cells. HECA-452 
also crossreacts with lymphoid tissue postcapillary venules in the 
ruminant  (M. A. Jutih, personal observation). 
In Vitro Binding Assay.  In all binding assays, human E-selectin- 
transfected  L cens (E-sdectin-L ceils) (generously  provided  by T. K. 
Kishimoto, Boehringer Ingelheim, Ridgefidd) or the parent cell 
line control were grown on eight-well  Labtek  slides (Miles Scientific, 
Naperville, IL) as previously described (27). Approximatdy 5  x 
105 PBMC, resuspended in 400 gl HB101 (Irvine Scientific, Santa 
Aria, CA) serum-free media, were allowed to adhere to the trans- 
fectants at room temperature for 30 min under constant rotation; 
the slides were then washed in HBSS (JRH Biosciences, Lenexa, 
KS) and fixed in 1% glutaraldehyde (Fisher Scientific, Fair Lawn, 
NJ). All mAbs used in the blocking assays  were at a final concen- 
tration of 50 gg/ml. Nenraminidase (Sigma Chemical Co.) treat- 
ment (1 U/ml in 50 mM NaOAc, pH 5.5, 154 mM NaCI, 4 mM 
CaClz) of the PBMC was performed at 37~  for 30 min. Simi- 
larly, PBMC were treated with chymotrypsin and trypsin (Sigma 
Chemical Co.) (100 U/m1 in HBSS) for 60 min at 37~  For the 
specific removal of leukocyte L-selectin, PBMC were treated with 
low-dose chymotrypsin (0.5 U/ml) or the chemical crosslinker BS  3 
(Pierce Chemical Co., Rockford, IL), as previously described (17, 
31, 32). After the various treatments, the PBMC were washed in 
HBSS, and the binding assay was performed as described above. 
All control experiments were performed under the same condi- 
tions as the treated cells,  but without addition of  the enzyme. After 
the binding assay, 7/8 T cells were revealed  by immunoperoxidase 
staining using a biotin-labeled IL-A29 mAb, streptavidin peroxi- 
dase (Tago, Inc., Burlingame,  CA), and amino-ethyl  carbazol (Sigma 
Chemical Co.). 
Immunofluorescence Staining and  FAC8  |  Analysis.  The  im- 
munofluorescence  staining procedure was carried out in 4-ml tubes 
(Becton Dickinson & Co., Mountain View, CA). Typically, 106 
cells per tube were initially incubated in 2% rabbit serum for 10 
min on ice to block Fc receptors. The ceils were washed and then 
incubated with primary antibody at 50 gg/ml (or undiluted cul- 
ture supernatant) for 20 min on ice. After washing, bound anti- 
bodies were revealed by incubation with PE-conjugated F(ab')2 
goat anti-mouse Ig (Tago, Inc.). FACS  |  analysis was performed 
on a FACScan  |  (Becton Dickinson & Co.) as previously  described 
01-34). In an analyses,  lymphocytes  were identified  by their unique 
forward and  side light scatters. For two-color  analysis, FITC- 
conjugated IL-A29 was used after staining with the primary mAb. 
Before  cells  were stained  with the FITC-conjugated  mAb, they were 
treated with 10% mouse serum to block any available  anti-mouse 
Ig binding sites  of the second  stage. Data were collected  from 10,000 
ceils and are presented as contour plots. 
EL-81-E-Selectin Sepharose 4B Column  Preparation.  The non- 
function-blocking, anti-E-selectin  mAb EL-81 (5 mg) was coupled 
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swollen bead volume) per manufacturer's  instructions.  Approxi- 
mately 3  x  10  s E-selectin-L cells were lysed in 2% NP-40 (Sigma 
Chemical Co.), 0.1 M NaC1 (Sigma Chemical Co.), 10 mM Hepes 
(Mediatech,  Washington,  DC),  1 mM CaCh (Sigma Chemical 
Co.), 1 mM MgCI2 (Sigma Chemical Co.), 5 mM NaN3 (Sigma 
Chemical  Co.),  with  10  /~g  each of  pepstatin,  leupeptin, 
chymostatin,  antipain,  benzamidine  HC1, 1, 10 phenanthroline, 
and I mM PMSF (Sigma Chemical Co.), and then centrifuged  at 
10,000g for 15 min. The lysate was incubated on the EL-81 column 
for 24 h at 4~  The EL-81-E-sdectin  column was then  duted 
with 0.1% NP-40, 0.1 M NaC1, 10 mM Hepes, 5 mM EDTA (Sigma 
Chemical Co.), 5 mM NaN3 and 1 mM PMSF to remove residual 
binding proteins left from the E-selectin-L cell lysate, and exten- 
sively washed with 0.1%  NP-40, 0.1 M NaC1, 10 mM Hepes, 1 
mM CaC12, 1 mM MgC12, 5 mM NAN3, and 1 mM PMSF. 
Purification of  the 7/d T Cell E-Selectin Receptor.  Bovine PBMC 
were collected, adherent cells removed by incubation in a polysty- 
rene flask at 37~  plus 10% CO2 for 1 h, and the nonadherent 
ceils (5  x  10  s) lysed as described above for the E-sdectin-L cells. 
Equivalent numbers of a mouse pre-B tumor cell line (L1.2) or a 
nonhematopoietic  tumor cell line (L cells) were lysed and used as 
controls for the E-selectin afl[inity column procedure. Lysates were 
precleared over an EL-81 column (no E-selectin) for 24 h at 4~ 
The predeared filtrate was collected, added to the EL-81-E-selectin 
column,  and incubated  for 24 h at 4~  The EL-81-E-sdectin 
column filtrate was collected, the column rinsed extensively with 
wash buffer, and duted with 5 ram ~  elution buffer. Samples 
were solubilized in 6 x  Laemmli's sample buffer, subjected to dec_ 
tmphoresis through an 8% SDS-polyacrylamide  gel under reducing 
or nonreducing conditions, and detected by silver stain analysis (Bio- 
Pad Laboratories, Richmond, CA) per manufacturer's instruction. 
Neurarainidase  Digestion of  Purified  Protein.  Protein purified from 
the EL-81-E-selectin column was neuraminidase digested, similar 
to the conditions described by Moore et al. (35) for optimal sialic 
acid removal. Protein-containing EDTA dution fractions were con- 
solidated and the buffer exchanged into a neuraminidase reaction 
buffer (0.15 M NaCI, 50 mM acetate, pH 6.0, 9 mM CaCh, 0.005 
mM NAN3, 0.005% NP-40) by use of a Centricon 30 concentrator 
(Amicon Corp.,  Beverly, MA). The digestion  was performed  at 
37~  for 10 h in the presence or absence of 500 mU/ml neuramini- 
dase from Arthrobacter ureafaciens (Calbiochem-Behring  Corp.,  La 
Jolla,  CA). 
TNF-cr Stimulation of Bovine Skin.  Approximately 5-10/zg of 
mouse TNF-cz (Genentech,  San Francisco, CA) in 200 #1 sterile 
HBSS was injected intradermally to raise a diffuse bleb. Tissue from 
stimulated and unstimulated  (contrahteral)  regions were collected 
and frozen in optimal cutting temperature compound (Miles Inc., 
Elkhart,  IN). 6-#m skin sections were cut, fixed in acetone, and 
blocked with 10-15% rabbit serum for 20 min. 7/~ or a/fl T cells 
were revealed by immunoperoxidase staining using the IL-A29 or 
CC42 mAbs, respectively. E-Selectin expression was detected by 
the EL-246 mAb. The primary mAbs were revealed by second-stage 
biotinylated anti-mouse antibody (Tago, Inc.); streptavidin perox- 
idase, and amino-ethyl carbazol. Tissue sections were also incubated 
with isotype-matched  negative control  mAbs to determine  any 
nonspecific binding of antibodies and/or endogenous  peroxidase 
development  of the substrates. 
Results 
Bovine 7/~ T Cells Bind E-Selectin cDNA-transfected Mouse 
L  Cells.  Isolated bovine mononuclear cells were tested for 
their ability to bind mouse L cells transfected with human 
E-selectin eDNA (E-sdectin-L cells). The binding assay was 
performed under rotation at room temperature. After the assay 
and fixation of bound cells, the 3//6 T lymphocytes were re- 
vealed by immunoperoxidase staining using a lineage-specific, 
anti-WC1 mAb. As shown in Fig. 1 A, bovine ~///~ T  ceils 
avidly bound the E-sdectin-L  cells,  but not the nontrans- 
fected parent cell line control (Fig. 1 B). Immunoperoxidase 
analysis demonstrated that 3'//~ T cells represented >90% of 
the mononuclear cells, when isolated from neonatal animals, 
that  bound  to  the  transfectants.  Monocytes and,  perhaps, 
memory T  ceils made up essentially the rest of the binding 
population. Like their human counterparts (5), bovine neu- 
trophils  also  bound  the  E-selectin  transfectants  (data  not 
shown). 
To address what percentage of the 3~//~ T cell population 
has the capacity to bind E-selectin, a mixed PBMC suspen- 
sion was sequentially passed over different monolayers of the 
E-sdectin transfectants. Greater than 90% of the 3//8 T cells 
bound E-sdectin and were removed from the PBMC popu- 
lation  (data not  shown). 
Characterization of the Binding Interaction between  "y/r  T Cells 
andE-Selectin.  We initially tested the effects ofanti-E-sdectin 
mAbs on the binding of 3~//~ T  ceils to E-selectin.  EL-246 
and CL2, which recognize the SCK and lectin domains of 
E-sdectin (27, 28), respectively, effectively blocked the binding 
interaction (Table 1). EL-81, which is a nonblocking,  anti- 
E-sdectin mAb (27), had little effect (Table 1). Neuramini- 
dase treatment of the 7/8 T ceils or addition of 5 mM EDTA 
to the binding assay also abrogated adhesion (Table 1). These 
results demonstrate that E-sdectin supports the adhesion of 
7/8 T  ceils and that  the binding  interaction  is dependent 
upon divalent cations. Furthermore, the apparent affinity neces- 
sary for 7/~ T cells to adhere to the E-sdectin-L cells during 
the rotational binding assay requires sialylated carbohydrates 
on  the  lymphocyte's cell surface.  These  characteristics  are 
similar to other previously defined leukocyte/E-sdectin in- 
teractions  (2,  36-40). 
Next we tested if bovine 7/~ T  cells are recognized by 
mAbs that bind carbohydrates that support E-selectin adhe- 
sion in other systems, such as CSLEX and HECA-452 (8, 
10, 36-40). In other studies we have found that HECA-452 
crossreacts in the ruminant and stains peripheral lymph node 
postcapillary venules (M. A. Jutila, unpublished observations), 
which is similar to its reactivity in the human  (30).  How- 
ever,  we found that  HECA-452  did not  recognize bovine 
PBMC (Fig. 2 a). The CSLEX mAb also crossreacted in the 
cow, but stained <~5% of bovine 7/~ T cells (Fig.  2 b). The 
lack of staining of bovine ~//$ T  cells was not due to poor 
antibody preparations,  since the HECA-452 and CSLEX mAbs 
did recognize human PBMC (Fig. 2, c and d, respectively). 
These results suggest that the sialylated carbohydrate struc- 
tures recognized by E-selectin on 3~/~ T  ceils are antigeni- 
cally different than previously characterized E-selectin carbo- 
hydrate ligands. 
In other systems, glycolipids and glycoproteins have been 
shown to present  E-selectin carbohydrate ligands  (41,  42). 
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bind E-sdectin-transfected  L cells. 
Bovine PBMC, isolated from neo- 
natal animals, were incubated with 
the E-sdectin-L cells (A)  or  the 
parent  cell line control (B) under 
nonstatic conditions at room tem- 
perature  as described in Materials 
and Methods. The y/~ T cells  were 
revealed  by  immunoperoxidase 
staining using the  mAb  IL-A29 
(arrow),  which  recognizes  the 
lineage-specific  WC1 antigen. Ap- 
proximate  magnification is 200. 
To address whether protein or lipid is important to the 3'/5 
T cell presentation of  E-selectin iigands, the effects of  different 
proteases on the binding interaction were tested. Table 2 shows 
that  chymotrypsin or trypsin treatment of bovine PBMC 
blocked binding by an average of 72 and 35%, respectively. 
Due to the protease sensitivity of the binding interaction, 
we examined the effects of three function-blocking antibodies 
against known glycoprotein adhesion molecules on 3,//t T 
cells (L-selectin, CD18,  and CD44) for an inhibitory effect 
on E-selectin binding. Table 2 shows that none of these anti- 
bodies effectively blocked binding. Because L-selectin on neu- 
trophils has been been proposed to be a ligand for E-selectin 
in the human (28,  42), and since 3'//~ T  cells express three 
to five times the level of this receptor as other leukocytes (Wal- 
check, B., manuscript in preparation), we examined the effects 
of other treatments that block L-selectin function. BS  3 or 
low-dose chymotrypsin (0.5 U/ml) treatments reduced the 
expression of L-selectin on the 3,/6 T  cells by >95%  (data 
not shown), which is the same result as seen with other leu- 
kocytes (17, 31, 32, 42); but these agents had no significant 
effect on the binding interaction (Table 2). Our results dem- 
onstrate that both sialylated carbohydrates and a protein corn- 
856  Bovine "y/6 T  Cells Bind E-Selectin Table  1.  Characterization of the Binding Interaction between 7/~ T  Cells and E-Selectin 
No. of "~//~ T cells/L  cell* 
Treatment of:  Treated  Control 
Percent inhibition 
of binding* 
E-selectin-L cells  s 
EL-246  0.9  _+  0.1  4.5  _+  1.0  79  _+  3.5 
CL2  1.6  +_  0.3  4.5  _+  1.0  64  _+  1.1 
EL-81  4.8  _+  1.0  4.5  +  1.0  ND 
EDTA  0  5.1  +  0.5  100 
T/~ T  cells  II 
Neuraminidase  0.1  _+  0.1  2.8  _+  1.6  98  _+  0.5 
*  3'/~ T  cell binding to the E-sdectin-L cells was quantified by counting three  separate fields at 20 x  power.  The mean number of 3'/~ T  cells 
per E-selectin-L  cell was determined for control and treated  cells. The values given represent  the mean from three  separate experiments  +  SE. 
t Percent inhibition of binding =  100 x  (control mean- treated  mean/control mean). The values given represent the mean inhibition from three 
separate experiments  _+ SE. 
S E-selectin-transfected  L cells were pretreated  with the anti-E-selectin mAbs EL-246, CL2, or EL-81 at 50 #g/ml for 30 min, and the binding 
assay was performed  as described in Materials and Methods.  5 mM EDTA was added to the E-selectin-L cells before the addition of the PBMC. 
3'//i T  cells, bound to the E-selectin-L  cells after the binding assay, were  revealed by immunoperoxidase  staining with the lineage-speeific mAb 
biotin-conjugated IL-A29. 
II PBMC  were  treated  with neuraminidase  (1 U/ml) before their addition to the E-selectin-L  cells. 
ponent are important  for T/~ T  cell binding to E-selectin, 
but that certain known adhesion molecules are likely not in- 
volved (further  evidence provided below). 
E-Selectin Binds a Single Glycoprotein in Detergent Lysates of 
"r/3 T Cells.  Purified E-selectin was immobilized on a sup- 
porting matrix to isolate putative receptors from a detergent 
lysate  of 3'//i  T  cells.  Sepharose  4B  beads  coupled  to  a 
nonfunction-blocking anti-E-sdectin antibody (EL-81) were 
used to capture detergent-solubilized E-selectin derived from 
the E-sdectin-L  calls.  T//~ T  cells were lysed in NP-40 to 
isolate functional cell surface membrane complexes; precleared 
on an EL-81 column, which removed a considerable amount 
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Figure 2.  Bovine PBMC lack significant expression of 
the sl.ex and HECA-452 carbohydrate moieties. PBMC 
were separated and stained for FACS  ~ analysis  by the mAb 
HECA-452. For two-color FACS  ~ analysis,  the 3'//$ T cells 
were stained by the mAbs FITC-conjugated  IL-A29 and 
CSLEX as described in Materials and Methods. (a) Level 
of HECAo452 expression on PBMC, which is equivalent 
to the level  of staining demonstrated  by an isotype-matched 
negative control antibody. (b) Level  of sLex expression on 
3'//$ and non-3"/6 T cells. Less than 5% of the 3"/6 T cells 
expressed sLex after background fluorescence  with an iso- 
type control mAb was subtracted out of the percentage 
of positive staining cx!ls. (c and d) sLex and HECA-452 
antigen expression on human PBMC,  respectively. Table  2.  The Effects of Function-blocking raAbs against 7/~  T  Cell Adhesion Glycoproteins on E-Selectin Binding 
No.  of 34/$  T  ceUs/L  cell* 
Treatment  Adhesion  Percent  inhibition 
of "y/6  T  cells  protein  Treated  Control  of binding* 
Hermes-3S  CD44  3.4  _+  0.6  3.5  _+  0.2  ND 
60.3  CD18  3.5  _+  0.5  3.5  +_  0.2  ND 
DKEG-56  L-Selectin  4.3  _+  0.3  3.5  +_  0.2  ND 
Chymotrypsin  (0.5  U/ml)ll  L-Selectin  1.9  +_  0.5  2.2  +_  0.3  ND 
BS  3  L-Selectin  2.0  +  0.6  2.2  _+  0.3  ND 
Chymotrypsin  (100  U/ml)  I  1.0  +_  0.4  4.6  _+  0.7  72  _+  9.3 
Trypsin  (100  U/ml)  3.2  _+  1.1  4.6  _+  0.7  35  +_  11 
* 3'/~ T  cell binding to the E-sdectin-L cells was quantified as described in Table 1. 
* Percent inhibition of binding  =  100 x  (control mean- treated mean/control mean). The values given represent the mean inhibition from three 
separate  experiments  +  SE. 
S 3,/8 T ceils were pretreated with the mAbs Hermes-3,  60.3,  or DKEG-56 at 50 #g/ml for 30 min, and the binding assay was performed as described 
in Table 1. 
II 3"//i T  cell L-selectin was removed from the call surface by treatment of these cells with low-dose chymotrypsin or the chemical  crosslinker BS  3 
as described  in Materials and Methods. 
I ~//6 T  cell surface membrane proteins were removed by protease treatment with chymotrypsin or trypsin as described in Materials and Methods. 
of  protein;  and  then  incubated  on  the  EL-81-E-selectin 
column. Materialbound to both the preclearing and E-selectin 
columns was eluted using a 5-mM EDTA elution buffer. As 
shown  in Fig.  3  A,  a  predominant  molecule  of m250  kD 
was extracted by the EL-81-E-sdectin  column  and detected 
in the elution fractions 3-6 (lanes 9-I2) by nonreducing SDS- 
PAGE and silver stain analysis. The 250-kD band was faintly 
Figure  3.  Silver stain analysis of a single 3'/6 T cell glycoprotein iso- 
lated from an E-selectin affinity column. (A) Samples from the respective 
steps involved in the purification of the E-sdectin ligand from a ~//~t T 
cell lysate were subjected  to electrophoresis  on 8% SDS-polyaerylamide 
gels under nonreducing conditions and revealed by silver stain analysis as 
described in Materials and Methods. Lanes 2 and 3 represent  the filtrates 
from a 3'/fi T  cell lysate sequentially  passed over the EL-81 preclearing 
column twice (lane 2, first passage; lane 3, second passage [arrow, presence 
of the 250-kD band]), lane 4 represents a sample of the consolidated EDTA 
elution fractions  3, 4,  and 5 from the EL-81 preclearing cohmn.  Lane 
5  represents  6 x  Laemmli's sample buffer plus running buffer.  Lane  6 
represents the filtrate of the precleared 348 T ceU lysate collected from the 
EL-81-E-selectin column (arrow, absence of the 250-kD band). Lanes 7-14 
represent the EDTA elution fractions 1-8, respectively, from the EL-81- 
E-sdectin column (arrow, presence of the 250-kD band). Lanes I and 15 
represent molecular mass markers, which are designated on the left of the 
figure by their respective mass. (B) The 250-kD product was run on an 
8% polyacrylamide  gel under nonreducing (lane 1) and reducing (lane 2) 
conditions. (C) Equal concentrations of the 250-kD product were neur- 
aminidase digested or sham treated, then reisohted by the E-seleetin affinity 
column (lanes 5 and 4, respectively).  An equivalent  number of a mouse 
pre-B (L1.2 cells) or nonhematopoietic (L cells) tumor cell line to ~//fi 
T cells were NlX40 solubilized and affinity column e~tracted as described 
above. EDTA elution fractions from the EL-81-E-selectin column from 
each lysate were consolidated and equal sample volumes  analyzed;  lane 
1,  L cells; lane 2, L1.2 cells; lane 3, 3'/~ T  cells. 
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detected in the ED~  dution fractions from the same column. 
The 250-kD was not detected in the E-selectin column filtrate 
(Fig.  3 A);  however, all other bands seen in the filtrate off 
the preclearing  column were still present  (compare lanes 2 
and 6). Some minor protein bands were present in the EL- 
81-E-selectin elution fractions as well. For instance, a mole- 
cule of 69 kD was detected; however, this molecule was also 
evident in the elution fractions off the preclearing  column 
and the filtrate from the E-selectin column (Fig. 3 A). Thus, 
we believe it interacted with EL-81  and/or  the supporting 
beads, but not  E-sdectin.  A  continuous  background band 
was also seen at  *46  kD,  which was generated by a con- 
taminating protein within the Laemmli's sample buffer. The 
E-selectin affinity-purified molecule migrated  at  *280  kD 
under  reducing  conditions  (Fig.  3  B),  which  consisted of 
solubilization at 37~  with 2-ME due to the 250-kD mole- 
cule's sensitivity to boiling  (it  may aggregate). 
As established above, the binding interaction between "y//~ 
T  cells and E-selectin is dependent upon sialic acid. Related 
studies by Moore et al.  (35) describing a myeloid glycopro- 
tein receptor for P-selectin have demonstrated the importance 
of sialic acid to the function of their molecule as well. Using 
the same neuraminidase enzyme, buffer, and incubation con- 
ditions  determined  by Moore et al.  to be optimal  for the 
removal of sialic  acid residues from their  glycoprotein,  we 
digested the purified 250-kD molecule to determine flit could 
be reisolated by the E-selectin affinity column. As shown in 
Fig. 3 C, reactivity of the 250-kD molecule with E-selectin 
was greatly  diminished  by prior  neuraminidase  digestion, 
though treatment of an equal concentration of the molecule 
under  the  same conditions  without  neuraminidase  had no 
apparent  effect on the binding  interaction.  Neuraminidase 
digestion of the 250-kD molecule decreased its mobility during 
SDS-PAGE (equivalent to 300 kD; data not shown), which 
is characteristic  of heavily sialylated glycoproteins (43,  44) 
Figure 4.  TNF-ot-induced,  endothelial cell E-selectin ~pression in skin is associated  with an accumulation of 7/~$ T cells at the same site. Bovine 
skin was stimulated for 6 h by intradermal injection of 10 ~g TNF-ot. Sections cut from control (A) and stimulated skin (B) samples were stained 
by immunoperoxidase using the 3,/c5 T cell-specific  mAb IL-A29 (arrow; v, venule). (C) TNF-ot-stimulated skin was stained with the anti-E-selectin 
mAb EL-246 (arrow, intense luminal staining). Approximate magnification is 200. 
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receptor for P-selectin (35). However, only the 250-kD mol- 
ecule, and not the slower mobility digested product (300 kD), 
was able to interact with E-sdectin. These results show that 
there are only a limited number of protein species (even under 
these low stringency conditions) that can be bound by E-sdec- 
tin. Furthermore, the 250-kD molecule's specificity  for E-selec- 
tin is EDTA and neuraminidase sensitive, the same as "y/~ 
T  cell binding to the E-selectin-L cells. 
We then tested for a similar E-selectin binding molecule 
in lysates generated from two tumor cell lines (L1.2 and L 
ceils). L1.2 ceils (mouse pre-B tumor cell line) demonstrated 
a low aflinity capacity to interact with the E-selectin-L cells 
(data  not shown). 5  x  10  s L1.2 cells were lysed and run 
over the preclearing and E-selectin columns as described above 
for the 3'//~ T cells. The EDTA elution fractions off the EL- 
81-E-selectin  column were consolidated, and the same was 
done with elution fractions from a 3'/~ T cell lysate of equiva- 
lent cell numbers. An equal sample volume (reflecting mate- 
rial from the same number of cells) from each of the two 
preparations was examined by silver stain analysis. Interest- 
ingly, a 250-kD molecule was isolated from the L1.2 ceils; 
however, the expression level was far less than on "y/~ T cells 
(Fig. 3 C), which correlated with the L1.2 cell's low E-sdectin 
binding capacity ('~,1:20 the capacity of 3'//~ T cells). Similar 
analysis was done with L cells, a mouse nonhematopoietic 
tumor cell line, in which the 250-kD molecule was not de- 
tected (Fig.  3 C). The 300-  and 200-kD proteins detected 
in the L cell elution fractions (Fig. 3 C) were duted off the 
preclearing column as well, indicating they were interacting 
with EL-81 and/or the supporting matrix, but not E-sdectin 
(data  not shown). 
Upregulation of E-Selectin in Bovine Skin Is Associated with 
Increased  7/~ T Cell Localization.  Animals of '~8 wk of age 
were  stimulated by  an  intradermal injection of 5-10  #g 
TNF-ol, a known inducer of E-selectin expression (5, 45), 
to examine "y//~ T cell recruitment. Sections cut from con- 
trol  and  stimulated  skin  samples  were  stained  by  im- 
munoperoxidase using the 3'/~ T ceil-specific mAb IL-A29, 
the a//3 T  cell-specific  mAb CC42, or the anti-E-selectin 
mAb EL-246. Fig. 4 A shows "y/~ T cells from a representa- 
tive region of control skin. Fig. 4 B shows 3'//~ T ceils from 
a representative region of TNl~-c~-stimulated skin (note the 
perivascular accumulation of V/6 T cells). The same TNF- 
o~-stimulated skin, stained with the anti-E-sdectin mAb EL- 
246, demonstrated intense luminal expression of E-sdectin 
on the dermal blood vessels (Fig. 4 C). Using serial cut sec- 
tions, we compared the ratio of 3'/~ T cells to c~/{3 T cells 
actively bound to the luminal surface of venules in TNF-c~- 
inflamed skin. This analysis allowed for the quantitation of 
newly recruited lymphocytes versus cells, both ~//~ and c~//3 
T  cells, that were already in the tissue before induction of 
inflammation. The 3'/6 to c~//3 T cell ratio in peripheral blood 
was '~0.7:1,  however,  the ratio found in inflamed dermal 
venules was 3.7:1 (determined from analysis of >200 cells). 
These results suggest that there is a correlation between the 
upregulation of E-sdectin expression  and increased 3~/6 T 
cell accumulation. 
Discussion 
E-selectin was originally defined as an inducible endothelial 
cell adhesion protein for myeloid cells (5, 45) and is believed 
to be important in regulating acute inflammatory responses. 
Recent studies have expanded the role of E-sdectin to serving 
as a putative vascular addressin in certain chronic inflamma- 
tory processes for a subset of human memory T cells (8-11). 
We add to these studies by demonstrating the capacity  of 
ruminant ~///~ T cells from neonatal and mature animals to 
bind E-selectin. This interaction is supported by our in vivo 
studies in which induction of E-sdectin expression by TNF-c~ 
in bovine skin is associated with an influx of 3'//~ T calls at 
the same site. Our analyses are directly relevant to the human, 
since a significant percentage of human 3//~ T cells express 
the HECA-452 epitope, which Berg et al. and Picker et al. 
(2, 8, 10-12, and see below) have shown corrdates precisely 
with the ability of lymphocytes to bind E-selectin,  and we 
have found that a small percentage of human lymphocytes 
that bind E-selectin are stained by anti--~//~ TCK mAbs (data 
not shown). Thus, E-selectin has the potential of regulating 
many diverse leukocyte-endothelial cell interactions that occur 
in different inflammatory settings. 
Norton et al. (46, 47) have suggested that particular tissues 
may constitutively express low levels of E-selectin on certain 
venules. If true, E-selectin may be involved in leukocyte ex- 
travasation  in the absence of overt inflammation. This hy- 
pothesis is directly relevant to 3'/~ T cells. The tissues that 
have been  shown  to  constitutively express  low levels of 
E-sdectin are the skin and gut: both are sites of 3~//~ T cell 
localization (13, 14). Preliminary analysis suggests that "y//~ 
T cells bind E-selectin more avidly than other leukocytes (data 
not shown). If true, low levels of E-selectin on certain venules 
may preferentially  recruit 3'//~ T cells and account for their 
localization in uninflamed skin and gut. Indeed, E-sdectin 
may serve the same role in certain extralymphoid tissues as 
the vascular addressins  play in lymph nodes and Peyer's  patches. 
In this study, we provide a preliminary characterization 
of the adhesive  mechanism used by ~//~  T  cells to bind 
E-sdectin. A previously described component of leukocyte 
receptors for E-sdectin is sialylated carbohydrates,  sLex on 
neutrophils (36, 39) and the HECA-452 epitope (CLA an- 
tigen) on human memory lymphocytes (8, 10) are examples 
of these carbohydrate structures. Sialylated carbohydrates ap- 
pear important in the binding of "y/~ T  cells to E-selectin 
as well, since neuraminidase treatment of the lymphocytes 
inhibits the interaction. However the CSLEX and HECA- 
452 mAbs do not recognize ~//~ T ceils, suggesting that ad- 
ditional  biological  carbohydrate  structures,  antigenically 
different from what has been described on myeloid cells and 
CLA + lymphocytes, are recognized by E-sdectin. 
The carbohydrate ligands are only a partial representation 
of the entire receptor for sdectins. It is likely that the biolog- 
ical receptors for the sdectins would also be composed of 
lipid or protein. Importandy, both P- and L-selectin have been 
shown to bind specific ceU surface glycoproteins with high 
affinity (35, 48).  The complete significance of this protein 
component has not been determined. Protein may provide 
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presented to the selectins (48). However, it is possible that 
certain regions of the protein backbone may participate in 
a protein-protein interaction with the selectins, in addition 
to the carbohydrate-lectin interaction. 
Studies addressing the nature of the biological receptor on 
leukocytes for adhesion to E-selectin vary considerably in their 
findings, sLex and the HECA-452 antigen are found on many 
different glycoproteins and glycolipids on the leukocyte sur- 
face, suggesting that a large number of molecules could poten- 
tially serve as receptors (42). However, this does not appear 
to be the case. Activation of neutrophils actually increases 
sLex expression, but binding to E-selectin is greatly dimin- 
ished (28,  42, 49).  Thus, there appears to be a restriction 
in the types of molecules on the leukocyte surface that can 
bind E-selectin. 
Putative glycoprotein receptors for E-selectin have been de- 
scribed on neutrophils. For example, L-selectin may prefer- 
entially present  sLex on neutrophils to  E-selectin.  Anti- 
L-selectin mAbs block neutrophil adhesion to E-sdectin cDNA 
transfectants to the same extent as anti-E-selectin mAbs, sug- 
gesting that E- and L-selectin  can serve as receptor-ligand 
pairs (28), Picker et al. (42) extended these observations and 
found that L-selectin is decorated by sLex, and its preferen- 
tial localization at the tips of the microvilli and ruffles of the 
neutrophil cell surface membrane may account for its pre- 
dominant role in presenting carbohydrates  to E-selectin.  A 
recent study by Vestweber et al. (50) has described an addi- 
tional glycoprotein (160 kD, reducing conditions) that can 
be isolated from detergent lysates of mouse neutrophils by 
an E-selectin  affinity column. However, an analogous role 
for L-selectin or any other single glycoprotein in mediating 
lymphocyte adhesion to E-selectin  has not been shown. 
We show that protein is a major component of the 3,/8 
T cell receptor for E-selectin.  Treatment of 3,/8 T cells with 
chymotrypsin or trypsin (to a lesser degree) blocks the binding 
interaction. L-Selectin,  CD44, and CD18, on 3"/8 T  cells 
do not appear to represent the surface receptor. In particular, 
three different approaches that block L-selectin function had 
no significant effect on 3"/8 T  ceU/E-selectin  adhesion. 
To address whether single or multiple cell surface glyco- 
proteins can potentially serve as E-selectin ligands, we exam- 
ined NP-40 solubilized membrane molecules from 3'/8 T cells 
by an E-selectin  affinity column. The affinity isolation ap- 
proach used here purified a single 250-kD glycoprotein that 
required sialic acid and divalent cations for an interaction with 
E-selectin.  A similar size molecule was not found in a lysate 
of a nonhematopoietic tumor cell line (L cells). Lysates of 
a lymphoid tumor cell line (L1.2) did contain the 250-kD 
molecule; however, the apparent expression level was much 
less than that from an equal number of 3"/8 T cells. The low 
expression of the putative E-selectin receptor by the L1.2 cells 
was not surprising for two reasons:  low numbers of L1.2 
cells are capable of binding E-selectin-L cells under rotation, 
and a recent study by Vestweber et al. (50) using an E-selectin- 
IgG fusion protein has identified a predominant 160-kD mol- 
ecule and a minor 250-kD molecule from detergent lysates 
of mouse leukocytes isolated from bone marrow. The 160- 
kD molecule appears to be myeloid specific, but the 250-kD 
molecule may have been derived from the minor bone marrow 
lymphocyte population. In consideration of the proposed gly- 
coprotein receptors for L- and P-selectin,  the 3'/~ T  cell 
receptor for E-selectin may represent an additional member 
of a potential new family of highly glycosylated surface pro- 
teins that serve as high affinity ligands for sdectins. 
It was beyond the intent of this study to provide a detailed 
biochemical characterization of the 250-kD molecule. Such 
analysis will include the generation of antibodies to deter- 
mine the biological significance of this molecule. Our affinity 
isolation technique allows for the purification of protein in 
the microgram range, thus, providing a significant quantity 
for immunizations. Antibodies will be necessary to defini- 
tively establish a functional role for the 250-kD molecule at 
the level of the in vitro binding assay and eventually in vivo. 
Interestingly, the molecule defined here is rdated in several 
ways to two other recently described molectdes: the proposed 
receptor for P-sdectin isolated from the surface of neutro- 
phils, which is ,v250 kD (under nonreducing conditions) 
(35);  and the WC1 antigens (also referred to as T19)  (14, 
19, 51, 52), a recently cloned, lineage-specific, 3'//$ T cell sur- 
face glycoprotein whose function is unknown (20). Because 
of the WC1 antigens' selective expression,  it has been pro- 
posed to be an epithelial-associated  tissue homing receptor 
for 3"/~ T calls (22). Immunoprecipitation of the WC1 an- 
tigen reveals a predominant molecular species of 165 kD (non- 
reducing conditions) (19). Some anti-WC1 antibodies im- 
munoprecipitate additional minor species with molecular 
masses above and below the 165-kD antigen (22). It is pos- 
sible the 250-kD glycoprotein defined here represents one of 
these minor forms of WC1. Our testing of this hypothesis 
to date has been incomplete; however, anti-T19 mAbs do not 
block 3"/8  T  cell  adhesion to E-selectin.  To confirm the 
similarity of these three proteins, antibodies generated against 
our 250-kD molecule will be tested for antigenic crossreac- 
tivity towards the receptor for P-sdectin and the WC1 an- 
tigens. 
In conclusion, our results provide the first demonstration 
that lymphocytes in an animal model bind E-sdectin. Rumi- 
nant 3"/8 T calls adhere to E-sdectin with high avidity and 
may use a previously undescribed 250-kD glycoprotein as their 
receptor.  To date, there has been no in vivo evidence that 
blocking E-selectin alters lymphocyte extravasation.  This is 
because virtually all studies of the interaction between lym- 
phocytes and E-selectin have been done in the human where 
reagents and assays are readily available, but homing experi- 
ments cannot be done. Defining lymphocyte-E-sdectin in- 
teractions in ruminants provides a significant  advancement 
because of the potential for in vivo analysis. Defining the 3'/8 
T cell system in ruminants is particularly advantageous be- 
cause these cells comprise 40-60% of the circulating T cell 
pool (14), and it can be expected that if their circulatory 
pathways  are  blocked  a  biological  effect  can  be  readily 
measured. 
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